Powered by

Oversight Committee Announces Major Hearings With Drug Company CEOs After Sweeping 18-Month Investigation

Sep 23, 2020 - Targeted News Service

Rep. Carolyn Maloney, D-New York, chairwoman of the House Oversight and Reform Committee, issued the following news release on Sept. 22:

Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, announced that the Committee will hold two days of hearings with top executives of major drug companies to examine their pricing practices for some of the costliest drugs in the United States. The hearings, titled "Unsustainable Drug Prices: Testimony from the CEOs," ...